lobbying_activities: 1450763

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1450763	495f701b-5bc0-4fdc-82b3-34bf579c7807	Q3	AMERICAN OPTOMETRIC ASSOCIATION	2981	AMERICAN OPTOMETRIC ASSOCIATION	2013	third_quarter	PHA	HR 1285, To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug, all sections relating to vision. S 621, Safe Prescribing Act of 2013, all sections relating to vision.	HOUSE OF REPRESENTATIVES,SENATE		280000	0	0	2013-10-18T11:54:13.927000-04:00